标题
Mechanisms of neuroblastoma regression
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 11, Issue 12, Pages 704-713
出版商
Springer Nature
发表日期
2014-10-21
DOI
10.1038/nrclinonc.2014.168
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo
- (2015) Zaowen Chen et al. NEOPLASIA
- EZH2 as a potential target in cancer therapy
- (2014) Michael T McCabe et al. Epigenomics
- Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma
- (2013) E. Barbieri et al. CANCER RESEARCH
- Insights into neural crest development and evolution from genomic analysis
- (2013) M. Simoes-Costa et al. GENOME RESEARCH
- Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
- (2013) Susan G Kreissman et al. LANCET ONCOLOGY
- Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study
- (2013) Gemma Gatta et al. LANCET ONCOLOGY
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics
- (2013) N.V. Batora et al. NEUROSCIENCE
- Distinct Neuroblastoma-associated Alterations of PHOX2B Impair Sympathetic Neuronal Differentiation in Zebrafish Models
- (2013) Desheng Pei et al. PLoS Genetics
- A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants
- (2012) Jed G. Nuchtern et al. ANNALS OF SURGERY
- DNA methylation inhibitors in cancer: Recent and future approaches
- (2012) Christina Gros et al. BIOCHIMIE
- Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
- (2012) G Schleiermacher et al. BRITISH JOURNAL OF CANCER
- The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
- (2012) Teeara Berry et al. CANCER CELL
- Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity
- (2012) K. R. Bosse et al. CANCER RESEARCH
- Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
- (2012) Nai-Kong V. Cheung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest
- (2012) Max M van Noesel LANCET ONCOLOGY
- Resolved and open issues in chromaffin cell development
- (2012) Klaus Unsicker et al. MECHANISMS OF DEVELOPMENT
- Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant
- (2012) M. Samy et al. MOLECULAR CANCER THERAPEUTICS
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
- (2012) Sharon J Diskin et al. NATURE GENETICS
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- (2012) Jan J Molenaar et al. NATURE GENETICS
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
- (2012) Mark Sausen et al. NATURE GENETICS
- Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
- (2012) L. C. Heukamp et al. Science Translational Medicine
- Neonatal neuroblastoma
- (2012) Jonathan P.H. Fisher et al. Seminars in Fetal & Neonatal Medicine
- Long-term Follow-up of the “Wait and See” Approach to Localized Perinatal Adrenal Neuroblastoma
- (2012) Denis Andrew Cozzi et al. WORLD JOURNAL OF SURGERY
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study
- (2011) Jane E. Minturn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The effect of P75 on Trk receptors in neuroblastomas
- (2011) Ruth Ho et al. CANCER LETTERS
- Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings
- (2011) Anneleen Decock et al. Epigenetics
- Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age
- (2011) Denah R. Taggart et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteomics-based identification of spontaneous regression-associated proteins in neuroblastoma
- (2011) Fang Yu et al. JOURNAL OF PEDIATRIC SURGERY
- Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
- (2011) E E Santo et al. ONCOGENE
- Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci
- (2011) Lễ B. Nguyễn et al. PLoS Genetics
- Assembling Neural Crest Regulatory Circuits into a Gene Regulatory Network
- (2010) Paola Betancur et al. Annual Review of Cell and Developmental Biology
- Lestaurtinib Enhances the Antitumor Efficacy of Chemotherapy in Murine Xenograft Models of Neuroblastoma
- (2010) R. Iyer et al. CLINICAL CANCER RESEARCH
- Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients
- (2010) E. Grau et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
- (2010) Malcolm A. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report
- (2010) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrative genomics identifies LMO1 as a neuroblastoma oncogene
- (2010) Kai Wang et al. NATURE
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
- (2010) David L. Baker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dependence receptors: a new paradigm in cell signaling and cancer therapy
- (2010) D Goldschneider et al. ONCOGENE
- Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
- (2009) Cinzia Lavarino et al. BMC CANCER
- On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
- (2009) C. J. Thiele et al. CLINICAL CANCER RESEARCH
- Trk Receptor Expression and Inhibition in Neuroblastomas
- (2009) G. M. Brodeur et al. CLINICAL CANCER RESEARCH
- Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
- (2009) R. Salcedo et al. JOURNAL OF IMMUNOLOGY
- Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
- (2009) Mario Capasso et al. NATURE GENETICS
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S
- (2008) Jean Bénard et al. Molecular Oncology
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Oncogenic mutations of ALK kinase in neuroblastoma
- (2008) Yuyan Chen et al. NATURE
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started